A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathy

Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):167009. doi: 10.1016/j.bbadis.2023.167009. Epub 2024 Jan 17.

Abstract

Urate oxidase (Uox)-deficient mice could be an optimal animal model to study hyperuricemia and associated disorders. We develop a liver-specific conditional knockout Uox-deficient (UoxCKO) mouse using the Cre/loxP gene targeting system. These UoxCKO mice spontaneously developed hyperuricemia with accumulated serum urate metabolites. Blocking urate degradation, the UoxCKO mice showed significant de novo purine biosynthesis (DNPB) in the liver along with amidophosphoribosyltransferase (Ppat). Pegloticase and allopurinol reversed the elevated serum urate (SU) levels in UoxCKO mice and suppressed the Ppat up-regulation. Although urate nephropathy occurred in 30-week-old UoxCKO mice, 90 % of Uox-deficient mice had a normal lifespan without pronounced urate transport abnormality. Thus, UoxCKO mice are a stable model of human hyperuricemia. Activated DNPB in the UoxCKO mice provides new insights into hyperuricemia, suggesting increased SU influences purine synthesis.

Keywords: Hyperuricemia mouse model; Urate nephropathy; Urate synthesis; Uricase-deficiency; de novo purine biosynthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Gene Knockout Techniques
  • Humans
  • Hyperuricemia* / genetics
  • Kidney Diseases* / genetics
  • Liver / metabolism
  • Mice
  • Mice, Knockout
  • Urate Oxidase / genetics
  • Urate Oxidase / metabolism
  • Uric Acid / metabolism

Substances

  • Uric Acid
  • Urate Oxidase